$2.67T
Total marketcap
$50.8B
Total volume
BTC 49.90%     ETH 17.07%
Dominance

Pharmagreen Biotech PHBI Stock

0.0007 USD {{ price }} -12.500001% {{change_pct}}%
Market Cap
464.55K USD
LOW - HIGH [24H]
0.0007 - 0.0007 USD
VOLUME [24H]
34.59K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD

Pharmagreen Biotech Price Chart

Pharmagreen Biotech PHBI Financial and Trading Overview

Pharmagreen Biotech stock price 0.0007 USD
Previous Close 0.0031 USD
Open 0.0031 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 0.0027 - 0.0031 USD
52 Week Range 0.001 - 0.02 USD
Volume 644K USD
Avg. Volume 416.4K USD
Market Cap 1.32M USD
Beta (5Y Monthly) 1.459141
PE Ratio (TTM) N/A
EPS (TTM) 0 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est N/A

PHBI Valuation Measures

Enterprise Value 1.75M USD
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1369.4767
Price/Book (mrq) N/A
Enterprise Value/Revenue 1816.143
Enterprise Value/EBITDA N/A

Trading Information

Pharmagreen Biotech Stock Price History

Beta (5Y Monthly) 1.459141
52-Week Change -66.66%
S&P500 52-Week Change 20.43%
52 Week High 0.02 USD
52 Week Low 0.001 USD
50-Day Moving Average 0.00416 USD
200-Day Moving Average 0.006195 USD

PHBI Share Statistics

Avg. Volume (3 month) 416.4K USD
Avg. Daily Volume (10-Days) 1.69M USD
Shares Outstanding 454.76M
Float 370.53M
Short Ratio N/A
% Held by Insiders 18.63%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends September 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End September 30, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) -73629.59%
Gross Margin -2.28%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -245.25%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 963 USD
Revenue Per Share (ttm) 0 USD
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA N/A
Net Income Avi to Common (ttm) -85817 USD
Diluted EPS (ttm) 0
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 7.39K USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 393.25K USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.036
Book Value Per Share (mrq) -0.004

Cash Flow Statement

Operating Cash Flow (ttm) -276014 USD
Levered Free Cash Flow (ttm) -749197 USD

Profile of Pharmagreen Biotech

Country United States
State BC
City Coquitlam
Address 2987 Blackbear Court
ZIP V3E 3A2
Phone N/A
Website https://www.pharmagreen.ca
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees N/A

Pharmagreen Biotech Inc., a biotech sciences solutions company, focuses on the production of starter plantlets for CBD hemp and medical cannabis industries. The company was incorporated in 2007 and is headquartered in Coquitlam, Canada.

Q&A For Pharmagreen Biotech Stock

What is a current PHBI stock price?

Pharmagreen Biotech PHBI stock price today per share is 0.0007 USD.

How to purchase Pharmagreen Biotech stock?

You can buy PHBI shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Pharmagreen Biotech?

The stock symbol or ticker of Pharmagreen Biotech is PHBI.

Which industry does the Pharmagreen Biotech company belong to?

The Pharmagreen Biotech industry is Drug Manufacturers-Specialty & Generic.

How many shares does Pharmagreen Biotech have in circulation?

The max supply of Pharmagreen Biotech shares is 663.65M.

What is Pharmagreen Biotech Price to Earnings Ratio (PE Ratio)?

Pharmagreen Biotech PE Ratio is now.

What was Pharmagreen Biotech earnings per share over the trailing 12 months (TTM)?

Pharmagreen Biotech EPS is 0 USD over the trailing 12 months.

Which sector does the Pharmagreen Biotech company belong to?

The Pharmagreen Biotech sector is Healthcare.